REMSleep receives clearance, details marketing plan
By HME News Staff
Updated 9:45 AM CDT, Thu July 18, 2024
CLEARWATER, Fla. – REMSleep Holdings has been awarded 510(K) clearance from the U.S. Food and Drug Administration for its new Deltawave CPAP Pillows Interface mask. With the clearance, the company has begun preparing the Deltawave for market by updating its website and ordering a large inventory. REMSleep has also announced a strategic marketing plan for Deltawave that includes identifying key distributors, providing comprehensive training to those distributors, expanding its reach, and launching marketing and awareness campaigns. "We are incredibly excited about the future of REMSleep and the tremendous potential of Deltawave,” said CEO Tom Wood. “Our journey ahead is filled with immense opportunities, but we recognize that it will require both strength and patience to achieve our corporate goals. We are committed to identifying and collaborating with the best distributors to ensure that Deltawave reaches those who need it most. Our team is dedicated to advancing our technology, expanding our market presence, and ultimately improving the lives of countless individuals affected by sleep apnea.” Deltawave’s features include the ability to support normal breath rate and a reduction in the need (or no need) for humidification.
Comments